Staphylococcal enterotoxin C2 expedites bone consolidation in distraction osteogenesis

Area of Science:

• Orthopaedic Research
• Regenerative Medicine
• Biomaterials Science

Background:

• Distraction osteogenesis (DO) is effective for bone defects but requires lengthy consolidation.
• Accelerating bone consolidation is crucial for improving DO outcomes.
• Staphylococcal enterotoxin C2 (SEC2) shows potential in modulating mesenchymal stem cell osteoclastogenesis.

Purpose of the Study:

• To investigate the effect of SEC2 on rat bone marrow derived mesenchymal stem cells (rBMSCs) proliferation and osteogenic differentiation.
• To evaluate the efficacy of local SEC2 administration in promoting bone consolidation in a rat DO model.

Main Methods:

• In vitro assessment of SEC2 on rBMSC viability, calcium deposition, and osteogenic gene expression.
• In vivo study using a rat DO model with local SEC2 administration.
• Analysis of bone regeneration using X-rays, micro-CT, mechanical testing, histology, and immunohistochemistry.

Main Results:

• SEC2 treatment increased calcium deposition and upregulated osteogenic markers in rBMSCs without affecting cell viability.
• In the rat DO model, SEC2 administration led to increased bone volume and improved bone quality.
• SEC2-treated tibiae exhibited significantly enhanced mechanical properties and upregulated osteocalcin and osterix expression at 6 weeks.

Conclusions:

• Local injection of SEC2 effectively promotes osteogenesis and enhances bone consolidation in distraction osteogenesis.
• SEC2 demonstrates potential as a novel therapeutic strategy to expedite bone healing in DO patients.